10Vinuesa C, de Lucas C, Cook M. Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens [J] . Postgrad Med J, 2001,77 (911) : 562-569.
3[1]Anderson Oberholzer,Cardine Oberholzer,Lyle L.Moldawer.Cytokine signaling-regulation of the immune response in critically ill states[J].Criti Care Med,2000,28(4):N3-N10.
4[2]Bone RC,Balk RA,Cara FB,et al.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis[J].Chest 1992;101:I644-655.
5[3]Steve Nelson.A Question of Balance[J].Am J Respir Crit Care Med,1999,159:1365-1367.[J].
6[4]Deitch EA.Animal models of sepsis and shock:a review and lessons learned[J].Shock,1998,9:1-11.
7[5]Peter McGuirk,Kingston HG Mills.Pathogen-specific regulator T cells provoke a shift in the Th1/Th2 paradigm in immunity to infections diseraes[J].Trends in immunology,2002,23(9):450-455.
8[6]Sean T O Sullivan,James A Lederer,Alan F Horgan,et al.Major injury leads to predominance of the T Helper-2 lymphocyte phenotype and diminished IL-12 production associated with decreased resistance to infection[J].Ann Surg,1995,222(4):482-492.
9Nogusa S, Ritz BW, Kassim SH, et al. Characterization of age - related changes in natural killer ceils during primary influenza infection in mice [ J ]. Mech Ageing Dev ,2008 ,129 ( 4 ) : 223 - 230.
